Back to search

Article

Effectiveness and Safety of COVID-19 Vaccination in People with Blood Cancer

2023-09-07

Abstract excerpt

Background: People with blood cancer have increased risk of severe COVID-19 outcomes and poor response to vaccination. We assessed the safety and effectiveness of COVID-19 vaccines against in this vulnerable group compared to the general population. <br><br>Methods: Individuals aged ≥12 years as of 1st December 2020 in the QResearch primary care database were included. We assessed COVID-19 vaccine effectiveness (V...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
26db2dad-6905-5f87-944c-361dc2dea31f
DOI
10.2139/ssrn.4557702
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness and Safety of COVID-19 Vaccination in People with Blood CancerDOI 10.2139/ssrn.4557702
Uptake of COVID-19 Vaccination in People with Haematological Malignancy and Other High-Risk Blood Disorders: Cohort Analysis of 12 Million Patients in EnglandSemantic proximity
Association of Cancer with Risk and Mortality of COVID-19: Results from the UK BiobankSemantic proximity
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity
Assessing COVID-19 Infection, and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern ItalySemantic proximity
Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemicSemantic proximity
Scottish COVID Cancer Immunity Prevalence (SCCAMP) - a Longitudinal Study of Patients with Cancer Receiving Active Anti-Cancer Treatment During the COVID-19 PandemicSemantic proximity
Impact of vaccination on the association of COVID-19 with arterial and venous thrombotic diseases: an OpenSAFELY cohort study using linked electronic health recordsSemantic proximity
Uptake, effectiveness and safety of COVID-19 vaccines in the immunocompromised population: A population-based cohort study in EnglandSemantic proximity
COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.Semantic proximity
Cancer and the Risk of COVID-19 Diagnosis, Hospitalisation, and Death: A Population-Based Multi-State Cohort Study Including 4,618,377 Adults in Catalonia, SpainSemantic proximity
Seroprevalence study prior and post vaccination in Cancer patients in Principality of Andorra (COVONCO study)Semantic proximity
Breakthrough SARS-CoV-2 Infections Among Patients with Cancer Following Two and Three Doses of COVID-19 mRNA VaccinesSemantic proximity
Select a neighboring publication to make it the new centre.